RITEMED Atorvastatin Calcium 10mg Film-Coated Tablet 1's
RXDRUG-DRP-1233-1pc
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Reduction of LDL-cholesterol (LDL-C) apolipoprotein B & triglycerides & to increase HDL-cholesterol (HDL-C) in the treatment of hyperlipidemias. As adjunctive therapy in patients w/ homozygous familial hypercholesterolemia who have some LDL-receptor function & for primary prophylaxis of CV events in patients w/ multiple risk factors.
Dosage/Direction for Use
10-80 mg once daily. Primary hypercholesterolemia & combined (mixed) hyperlipidemia 10 mg once daily. Homozygous familial hypercholesterolemia 80 mg w/ >15% reduction in LDL-C.
Administration
May be taken with or without food: Avoid excessive consumption (>1 L/day) of grapefruit juice.
Contraindications
Hypersensitivity. Active liver disease or unexplained persistent elevations of serum transaminases. Women of childbearing potential. Pregnancy & lactation.
Special Precautions
History of liver disease. Consumption of substantial quantities of alcohol. Perform liver function tests prior to & 12 wk following initiation of therapy & periodically thereafter. Rare cases of rhabdomyolysis w/ acute renal failure secondary to myoglobinuria. Discontinue use if markedly elevated creatine phosphokinase levels occurs or myopathy is diagnosed or suspected. Concomitant use w/ ketoconazole, spironolactone & cimetidine. Discontinue or temporary withheld in patients w/ severe acute infection, hypotension, major surgery, trauma, metabolic, endocrine & electrolyte disorders & uncontrolled seizures. Childn <18 yr.
Adverse Reactions
GI, resp, nervous, musculoskeletal, skin & appendages, urogenital, CV, hemic & lymphatic disorders; eye disorders & taste disturbances. Chest pain, face & generalized edema, fever, neck rigidity, malaise, photosensitivity reaction.
Drug Interactions
Increased risk of myopathy w/ cyclosporine, gemfibrozil/fibric acid derivatives, erythromycin, azole antifungals or niacin. Increased plasma conc w/ CYP450 3A4 inhibitors (eg, macrolide antibiotics, grapefruit juice & PIs), substrates & other drugs metabolized by this isoenzyme. Increased risk of myopathy & bioavailability w/ P-glycoprotein inhibitors. May increase conc of digoxin, OC-containing norethisterone & ethinyl estradiol. Reduced plasma conc w/ colestipol, oral antacid susp containing Mg & Al hydroxides. Minimal decrease in prothrombin time w/ warfarin.
MedsGo Class
Dyslipidaemic Agents
Features
Brand
RiteMed
Full Details
Dosage Strength
10mg
Drug Ingredients
- Atorvastatin
Drug Packaging
Film-Coated Tablet 1's
Generic Name
Atorvastatin Calcium
Dosage Form
Film-Coated Tablet
Registration Number
DRP-1233
Drug Classification
Prescription Drug (RX)
View all variations as list
| CODE | Dosage Strength | Drug Packaging | Availability | Price | ||
|---|---|---|---|---|---|---|
|
RXDRUG-DRP-1233-1pc
|
In stock
|
₱1400 |
Please sign in so that we can notify you about a reply